FGWLF yields 3.44% · PFE yields 6.13%● Live data
📍 FGWLF pulled ahead of the other in Year 1
Combined, FGWLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FGWLF + PFE for your $10,000?
Flughafen Wien Aktiengesellschaft, together with its subsidiaries, engages in the construction and operation of civil airports and related facilities in Austria. It manages the Vienna airport. The company operates through five segments: Airport, Handling & Security Services, Retail & Properties, Malta, and Other. The company's Airport segment operates and maintains aircraft movement areas and terminals, as well as equipment and facilities for passenger and baggage handling, as well as security controls for passengers. This segment also offers various services to support airport operations, deal with emergencies and disruptions, and ensure security. Its Handling & Security services segment provides various services for the handling of aircraft and passengers on scheduled and charter flights, as well as for the handling of general aviation aircraft and passengers. This segment also operates the general aviation center; and provides security controls for passengers and hand luggage. The company's Retail & Properties segment offers services that support airport operations, including shopping, food and beverages, VIP, lounges, and parking, as well as develops and markets properties. Its Malta segment operates Malta airport; and provides parking services, as well as rents retail and office space. The Other segment offers technical and repair, energy supply and waste disposal, telecommunication, and information technology, electromechanical and building, construction management, and consulting services, as well as construction and maintenance services for infrastructure facilities. The company is headquartered in Schwechat, Austria.
Full FGWLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.